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The 70 kDa S6 Kinase Complexes with and
Is Activated by the Rho Family G Proteins
Cdc42 and Rac1
Margaret M. Chou and John Blenis against pp70S6k into the nucleus or cytoplasm of rat fibro-
blasts inhibits DNAsynthesis (Lane et al.,1993; ReinhardHarvard Medical School
et al., 1994).Department of Cell Biology
Although pp70S6k is activated by numerous mitogenicBoston, Massachusetts 02115
stimuli, until recently little was known about how these
signals lead to activation of the enzyme. Using a variety
of receptor mutants, it was shown that phosphatidylino-Summary
sitol 3-kinase (PI3K) is a key mediator of pp70S6k activa-
tion in response toplatelet-derivedgrowth factor (PDGF),The 70 kDa ribosomal S6 kinase (pp70S6k) plays an
interleukin-2 (IL-2), and insulin (Cheatham et al., 1994;important role in the progression of cells through G1
Chung et al., 1994; Monfar et al., 1995). These studiesphase of the cell cycle. However, little is known of
were complemented by the use of two specific andthe signaling molecules that mediate its activation.
structurally unrelated PI3K inhibitors, wortmannin andWe demonstrate that Rho family G proteins regulate
LY294002, both of which block mitogen-induced pp70S6kpp70S6k activity in vivo. Activated alleles of Cdc42 and
activation. In addition, expression of a constitutively ac-Rac1, but not RhoA, stimulate pp70S6k activity in multi-
tivated PI3K molecule stimulated pp70S6k activity in vivople cell types. Activation requires an intact effector
(Weng et al., 1995). Together, these results confirmeddomain and isoprenylation of Cdc42 and Rac1. Coex-
that PI3K mediates either all or a large majority of pp70S6kpression of Dbl, an exchange factor for Cdc42, also
activation, depending on the agonist tested.activates pp70S6k . Growth factor±induced activation
Another crucial regulator of pp70S6k is FRAP, the directof pp70S6k is abrogated by dominant negative alleles
target of rapamycin (Brown et al., 1994; Sabatini et al.,of Cdc42 and Rac1. In addition, Cdc42 and Rac1 form a
1994; Sabers et al., 1995). FRAP encodes a protein withGTP-dependent complexwith thecatalytically inactive
homology to PI3K and exhibits rapamycin-sensitive pro-form of pp70S6k in vitro and in vivo, suggesting a mech-
tein kinase activity (Brown et al., 1995). However, theanism by which these G proteins activate pp70S6k.
precise mechanism by which FRAP or PI3K contributes
to pp70S6k activation remains unknown.
Introduction The Rho family of G proteins, which includes Rho,
Rac, and Cdc42, controls various aspects of cytoskele-
The 70 kDa S6 kinase (pp70S6k) plays an important role tal organization (Kozma et al., 1995; Nobes and Hall,
in the progression of cells from G1 to S phase of the 1995; Ridley and Hall, 1992; Ridley et al., 1992). Recently,
cell cycle (Bierer et al., 1990; Chung et al., 1992; Dumont they have also been shown to function in the regulation
et al., 1990; Kuo et al., 1992). pp70S6k is activated by of kinase cascades. For example, Cdc42 and Rac di-
virtually all mitogenic stimuli, including growth factors, rectly bind to and activate a family of highly related
cytokines, phorbol esters,and oncogeneproducts. Max- serine/threonine kinases referred to as p21-activated
imal activation of pp70S6k occurs within 5±30 min of stim- kinases (PAKs) (Manser et al., 1994). Cdc42 and Rac also
ulation, and in many cases pp70S6k activity remains ele- regulate the mitogen-activated protein kinase (MAPK)
vated throughout G1 (Chou and Blenis, 1995; Ferrari and homologs Jun N-terminal kinase (JNK) and p38 (Coso
Thomas, 1994). et al., 1995; Minden et al., 1995; Bagrodia, et al., 1995).
Compelling evidence for the role of pp70S6k in cell Furthermore, all three Rho family members regulate
cycle progression comes from studies using the immu- transcription of the c-fos proto-oncogene (Hill et al.,
nosuppressant rapamycin. Rapamycin causes G1 arrest 1995).
in T lymphocytes and other hematopoietic lineages and It has been shown that Rho family G proteins and
significantly delays S phase entry in fibroblasts (Calvo PI3K reside on a common signaling pathway, and most
et al., 1992; Chou and Blenis, 1995; Chung et al., 1992; studies indicate that PI3K functions upstream of the G
Kuo et al., 1992; Price et al., 1992). Rapamycin prevents proteins. Forexample, wortmannin preventsbothPDGF-
activation of pp70S6k by all known agonists. While pp70S6k induced GTP loading of Rac1 and membrane ruffling,
is not the direct target of rapamycin, it is likely to be a and the latter can be restored by microinjection of acti-
proximal effector since inactivation by the drug occurs vated Rac1 (Ridley et al., 1992; Hawkins et al., 1995;
within minutes (Chung et al., 1992). Furthermore, inhibi- Nobes et al., 1995). Furthermore, the regulatory subunit
tion is highly specific, as the kinase most closely related of PI3K, p85, binds toa GTPase-activating protein (GAP)
to pp70S6k, the 90 kDa S6 kinase (RSK), is resistant to for Cdc42 in vitro (Barfod et al., 1993). However, other
the drug (Chung et al., 1992). Since no other kinases, studies reveal that p85 binds to GTP-bound Cdc42 and
other than the direct target of rapamycin, FK506-binding Rac1, suggesting that PI3K may be a downstream ef-
protein (FKBP)±rapamycin-associated protein (FRAP; fector (Tolias et al., 1995; Zheng et al., 1994).
also called TOR or RAFT), have been found to be rapidly Given the link between PI3K and Rho family G proteins
inhibited by rapamycin, it is highly likely that pp70S6k is and the documented role of PI3K in activation of pp70S6k,
a relevant mediator of rapamycin-induced G1 arrest. we examined the role of these G proteins in the regula-
More direct support for the role of pp70S6k in G1 to S tion of pp70S6k. In the current study, we demonstrate
transit is provided by microinjection experiments, which that activated Cdc42 and Rac1, but not RhoA, stimulate
pp70S6k in vivo. Activation of endogenous Cdc42 bydemonstrate that introduction of neutralizing antibodies
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forced expression of the guanine nucleotide exchange would likely activate MAPK. Thus, activation of pp70S6k
factor (GEF) diffuse B cell lymphoma protein (Dbl) also by these G proteins is specific.
stimulates pp70S6k activity. Furthermore, dominant neg- Activation of pp70S6k by Cdc42 and Rac1 was also
ative alleles of Cdc42 and Rac1 abrogate PDGF- and demonstrated in growing BHK cells, in which basal
epidermal growth factor (EGF)-induced activation of pp70S6k activity is relatively high. Nevertheless, expres-
pp70S6k. We provide data on the mechanism of this ac- sion of both the wild-type and GTPase-deficient alleles
tivation by showing that Cdc42 and Rac1 associate of Cdc42 and Rac1 led to further activation of pp70S6k
specifically with the hypophosphorylated isoforms of (Figure 1C). Thus, the effects of Cdc42 and Rac1 on
pp70S6k in a GTP-dependent manner in vitro. This inter- pp70S6k occur in multiple cell types.
action was reproduced in vivo with activated but not
dominant negative and effector domain mutants of Activation of pp70S6k Requires the Effector
Cdc42. Although complex formation does not directly Domain and Proper Subcellular
activate pp70S6k, Cdc42 and Rac1 facilitate its activation Localization of Cdc42 and Rac
by other growth-promoting signals. We propose that the
A small region of p21ras between amino acids 30±40,
regulation of pp70S6k by Cdc42/Rac1 is analogous to the
termed the effector domain, mediates its interaction with
regulation of Raf by p21ras.
effectors. Mutations in this sequence prevent associa-
tion with its targets and thereby abrogate the trans-Results
forming potential of activated p21ras (Zhang et al, 1990;
Self et al., 1993). Analogous mutants of Rho family GCdc42 and Rac1, but Not RhoA, Activate pp70S6k
proteins are also deficient in downstream signaling
To determine whetherRho family G proteinsplay a role in
(Diekmann et al., 1994; 1995; Zheng et al., 1994). Indeed,the regulation of pp70S6k, NIH 3T3 cells were transiently
mutation of the effector domain rendered Rac161L inca-cotransfected with hemagglutinin epitope±tagged
pable of activating pp70S6k (mutant Rac161L40K, Figurepp70S6k (HA-pp70S6k) and the activated GTPase-deficient
1D). An effector domain mutant of Cdc42 similarly failedalleles of Cdc42, Rac1, or RhoA (Cdc42V12, Rac1V12,
to stimulate S6 kinase activity (see Figure 7B).and RhoV14, respectively) fused to glutathione S-trans-
The p21ras-related G proteins are modified by isopren-ferase (GST). The activity of HA-pp70S6k was monitored
ylation, which directs them to a membranous compart-by immunoprecipitation with anti-HA antibody, followed
ment. The isoprenoid groups are covalently attached toby in vitro kinase assays using S6 as substrate. Cotrans-
a cysteine residue near the C-terminus of the protein.fection of pp70S6k with Cdc42V12 or Rac1V12 stimulated
Mutation of this cysteine to serine results in aberrantS6 kinase activity in serum-starved cells to levels com-
localization. In the case of p21ras, which is normally foundparable to those induced byPDGF incontrol cells (Figure
at the plasma membrane, this mutant remains in the1A). Little or no further increase was obtained in re-
cytoplasm and loses its transforming ability (Hancocksponse to PDGF, suggesting that the activated G pro-
et al., 1990). Ablation of the isoprenylation site reversedteins induce maximal pp70S6k activation. A distinct acti-
the capacity of activated Cdc42 and Rac1 (mutantvated allele of Rac1, denoted Rac161L, also stimulated
Cdc42V12-C189S, Figure 1D; mutant Rac1V12-C189S,pp70S6k activity under serum-starved conditions (Figure
data not shown) to stimulate pp70S6k activity in serum-1D). Similar results were obtained in Chinese hamster
starved cells. These results indicate that Cdc42 andovary (CHO) cells (data not shown). The effects of Cdc42
Rac1 must be properly localized to activate pp70S6k.and Rac1 were specific, as coexpression of RhoA had
no effect on pp70S6k activity (Figure 1A).
Mitogenic stimulation induces the phosphorylation of Dbl, a Guanine Nucleotide Exchange Factor
multiple sites on pp70S6k, causing a reduction in its elec- for Cdc42, Activates pp70S6k
trophoretic mobility. By immunoblot analysis, pp70S6k Small GTP-binding proteins are regulated by the coordi-
can be resolved into a quadruplet of bands. Only the nate action of GAPs and GEFs. Upon appropriate stimu-
hyperphosphorylated band of slowest mobility is cata- lation, GEFs catalyze the exchange of GTP for GDP,
lytically active (unpublished data). Anti-HA immunoblot- leading to the activation of G proteins. The Dbl oncogene
ting of whole cell extracts confirmed that Cdc42 and product is a GEF that regulates Cdc42 and RhoA in vitro
Rac1, but not RhoA, stimulate the phosphorylation and (Hart et al., 1991; Hart et al., 1994). Cotransfection of
activation of HA-pp70S6k (Figure 1B). Furthermore, it veri- HA-pp70S6k with Dbl was found to activate S6 kinase
fied that the observed increase in S6 kinase activity was activity in serum-starved cells to levels comparable to
not simply due to higher levels of HA-pp70S6k expression
those induced by EGF (Figure 2) or by PDGF (data not
in the Cdc42- and Rac1-transfected samples. To ex- shown). As seen with cotransfection of Cdc42V12, little
clude the possibility that the GST moiety of the G protein
or no further activation was seen upon growth factor
constructs led to artifactual activation of pp70S6k, HA-
treatment in the Dbl-transfected cells (Figure 2). Thus,
tagged versions of Cdc42 and Rac1 were also tested,
stimulation of endogenous Cdc42 via expression of a
and identical results were obtained (data not shown).
GEF can also augment transfected pp70S6k activity.To determine whether the activation of pp70S6k by
Cdc42 and Rac1 was specific, the G proteins were ex-
Dominant Negative Cdc42 and Rac1amined for their effects on MAPK . Cotransfection with
Prevent Growth Factor±InducedRac1V12 (Figure 1A) or Cdc42V12 (data not shown)
pp70S6kActivationfailed to activate myc epitope±tagged MAPK (myc-
If Cdc42 and Rac1 mediate signaling from growth factorMAPK). This result argues against the possibility that
receptors to pp70S6k, then dominant negative versions ofCdc42 and Rac1 activate pp70S6k indirectly through the
production of autocrine factors, since such factors these G proteins might be expected to abrogate growth
p70 S6 Kinase Regulation by Rho G Proteins
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Figure 1. Specific Activation of pp70S6k by Cdc42 and Rac1, but Not RhoA
(A) NIH 3T3 cells were cotransfected with HA-pp70S6k (or myc-MAPK) and GST fusions of the indicated activated G proteins, or the control
GST vector, pEBG. Cells were starved for 24 hr, then stimulated with PDGF (4 ng/ml) for 30 min. Lysates were immunoprecipitated with anti-
HA (or anti-myc) antibody, then subjected to in vitro kinase assays using S6 (or MBP) as substrate. Results are representive of at least five
experiments.
(B) Whole cell lysates of the transfectants described in (A) were fractionated and probed with anti-HA or anti-GST antibody. Myc-MAPK
expression was uniform in all samples (data not shown). Detection was via ECL.
(C) BHK cells were cotransfected with HA-pp70S6k and the wild-type or activated alleles of Cdc42 or Rac1. Growing cells were lysed, and anti-
HA immunoprecipitates were assayed for S6 kinase activity and quantitated on a phosphorimager. Data represent the average of at least
three experiments.
(D) NIH 3T3 were cotransfected with HA-pp70S6k and GST-tagged Cdc42V12-C189S, myc-tagged Rac161L, or Rac161L40K. Cells were treated
and assayed as above. Top, S6 kinase assay. Bottom, anti-HA immunoblot. Expression of the two Rac alleles was equivalent (data not shown).
Data are representative of at least three experiments.
factor±induced pp70S6k activation. Dominant negative Cdc42N17 and Rac1N17 had little effect on the activa-
tion of myc-MAPK (data not shown). Together, thesealleles were generated through substitution of Thr at
position 17 to Asn. The analogous mutation in p21ras data provide strong evidence that Cdc42 and Rac1 play
a specific and direct role in growth factor±dependentincreases its affinity for GDP. This results in sequestra-
tion of GEFs, making them unavailable for activation of activation of pp70S6k.
endogenous p21ras and thereby blocking downstream
signaling events. The N17 mutants of Cdc42 and Rac1
have similarly beenshown to function as dominant nega- Activation of pp70S6k Is Independent
of JNK and p38tive molecules (Coso et al., 1995; Kozma et al., 1995;
Minden et al., 1995). Recently, much attention has been focused on the reg-
ulation of the MAPK homologs JNK (also referred toAs shown in Figure 3, expression of Cdc42N17 or
Rac1N17 blocked the majority of EGF- and PDGF-in- as stress-activated protein kinase, SAPK) and p38.
Whereas MAPK is activated by mitogenic stimuli suchduced activation of pp70S6k. During the course of these
experiments, it was noted that Cdc42N17 and Rac1N17 as growth factors and phorbol esters, JNK and p38 are
activated by agents that induce cellular stress (Canoinhibit cell growth (unpublished data; Olson et al., 1995).
To rule out the possibility that abrogation of pp70S6k and Mahadevan, 1995; Minden et al., 1994; Raingeaud
et al., 1995). These include inflammatory cytokines suchactivity was an indirect consequence of this inhibition,
MAPK was also monitored in cells coexpressing the as tumor necrosis factor a (TNFa) and interleukin-1
(IL-1), osmotic shock, heat shock, ultraviolet irradiation,dominant negative G proteins. As previously reported,
Cell
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Figure 3. Dominant Negative Alleles of Cdc42 and Rac1 Abrogate
PDGF- and EGF-Induced Activation of pp70S6k
NIH 3T3 cells were cotransfected with HA-pp70S6k and GST fusions
of Cdc42N17, Rac1N17, or pEBG. Cells were starved for 24 hr, then
stimulated with PDGF or EGF. Lysates were immunoprecipitated
with anti-HA antibody, then subjected to S6 kinase assays. S6 phos-
phorylation was quantitated and expressed as fold activation over
the activity in serum-starved cells. Data represent the results of at
least four experiments.
To address whether p38 might act upstream of
pp70S6k, we tested the effects of MKK3, the p38-activat-Figure 2. The Guanine Nucleotide Exchange Factor Dbl Activates
pp70S6k In Vivo ing kinase, on pp70S6k activation (DeÂ rijard et al., 1995).
Cotransfection of a dominant negative allele of MKK3(A) NIH 3T3 cells were transiently cotransfected with HA-pp70S6k
and Dbl. Cells were starved for 24 hr, then stimulated with EGF (100 (MKK3A) (Whitmarsh et al., 1995) blocked sorbitol-in-
ng/ml) for 10 min. Lysates were immunopecipitated with anti-HA duced activation of epitope-tagged p38, but it had no
antibody and assayed for S6 kinase activity. Results represent the effect on activation of pp70S6k by EGF or PDGF (Figure
data from at least three experiments.
4C). We also found that activation of p38 occurred in(B) Anti-Dbl immunoblot of transfectants described in (A).
the presence of rapamycin (data not shown), indicating(C) Quantitation of S6 phosphorylation in (A).
that pp70S6k does not function upstream of p38. Taken
together, these results strongly suggest that p38 andand inhibitors of protein synthesis. The effects of mito-
JNK reside on a signaling pathway distinct from pp70S6k.genic growth factors on JNK and p38 are less clear,
with different investigators reporting either no activation
Rapamycin and Wortmannin Block Activationor moderate activation (Cano and Mahadevan, 1995;
of pp70S6k by Cdc42 and Rac1Minden et al., 1994; Raingeaud et al., 1995). These dispa-
Two key regulators of pp70S6k are FRAP and PI3K. FRAPrate results are most likely due to the use of distinct cell
activity is absolutely required, as inhibition of FRAP bytypes, as well as to clonal variations within a given cell
rapamycin prevents activation of pp70S6k by all agonists.type. Recently, it has been demonstrated that in cases
Thus, it was not surprising that rapamycin reducedwhere growth factors do activate JNK and p38, this
pp70S6k activity to below basal levels in Rac1V12-trans-stimulation is mediated by Cdc42 and Rac1 (Coso et
fected cells (Figures 5A±5C). Interestingly, the PI3K in-al., 1995; Minden et al., 1995; Bagrodia et al., 1995).
hibitor wortmannin also blocked phosphorylation andThe question therefore arose of whether pp70S6k and
activation of pp70S6k by Rac1V12 (Figures5A±5C). Identi-JNK/p38 lie on a common signaling pathway. To explore
cal results were obtained with Rac1V12 in the absencethis issue, we measured theactivity of the three enzymes
of PDGF and with Cdc42V12 (data not shown). Thesein response to PDGF and EGF in NIH 3T3 cells. While
data suggest that either PI3K functions downstream ofboth growth factors induced the rapid activation of
the G proteins or that it generates a parallel signal re-pp70S6k, neither had any effect on JNK in ourcells (Figure
quired for the activation of pp70S6k (see next section).4). This was not due to mutation or absence of the JNK
protein, as treatment of the cells with sorbitol (to induce
Cdc42 Does Not Stimulate pp70S6kosmotic shock) potently stimulated its ability to phos-
via Activation of PI3Kphorylate recombinant GST±c-Jun. At the same time,
The above results indicate that a PI3K-dependent signalsorbitol failed to activate pp70S6k and even consistently
is required for Cdc42/Rac1-mediated activation ofinhibited its activity to below basal levels (Figure 4). In
pp70S6k. Previous studies have shown that Cdc42 cancontrast with JNK, p38 was activated by EGF and PDGF,
bind to the p85 regulatory subunit of PI3K in a GTP-albeit to a much lesser degree than by sorbitol (2.0- to
2.5-fold versus 12- to 13-fold, Figures 4A and 4B). dependent manner, and one group further suggested
p70 S6 Kinase Regulation by Rho G Proteins
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Figure 4. Growth Factor±Induced Activation
of pp70S6k Is Independent of JNK and p38
(A) NIH 3T3 cells were starved for 24 hr, then
stimulated with EGF, PDGF, or sorbitol (400
mM) for 10 min and 30 min. Lysates were
prepared and immunoprecipitated with anti-
pp70S6k, anti-JNK, or anti-p38 antiserum. Im-
munocomplexes were subject to in vitro ki-
nase assays using S6, GST±c-Jun, or GST±
ATF2 as substrate, respectively.
(B) Quantitation of S6, GST±c-Jun, and GST±
ATF2 phosphorylation in (A).
(C) FLAG-tagged p38 (left) or HA-pp70S6k
(right) was cotransfected with pEBG or
FLAG±MKK3A into NIH 3T3 cells. Cells were
starved, then stimulated for 30 min with sorbi-
tol (S) (for FLAG±p38 transfectants) or EGF
(E)/PDGF (P) (for HA-pp70S6k transfectants).
Kinase assays were performed on p38 using
GST±ATF2 as substrate or on pp70S6k using
S6 (top). Bottom, anti-FLAG immmunoblots
demonstrating MKK3A expression. Expres-
sion of FLAG±p38was comparable in all sam-
ples as was HA-pp70S6k, (data not shown).
that this results in a weak activation of PI3K in vitro and p120ACK, serine/threonine and tyrosine kinases, re-
(Zheng et al., 1994). However, others have been unable spectively, which directly bind to and are activated by
to obtain any stimulation of PI3K activity (L. C. Cantley, Cdc42/Rac1 (Manser et al., 1993; 1994). To understand
personal communication). Furthermore, there is no pub- the mechanism of pp70S6k activation, we tested whether
lished evidence that Cdc42 activates PI3K in vivo. any of the Rho family members could form a complex
The serine/threonine kinase Akt was recently identi- with pp70S6k. GST fusions of Cdc42, Rac1, and RhoA
fied as a downstream target of PI3K (Franke et al., 1995; were expressed in Escherichia coli and purified over
Burgering and Coffer, 1995). If Cdc42 were activating
a glutathione agarose affinity column (Figure 6A). The
PI3K in vivo, one would expect that cotransfection with
recombinant proteinswere loaded with GTPgS (a nonhy-
Cdc42V12 would result in activation of Akt. However,
drolyzable analog of GTP) or GDP, then incubated withthere was no difference in Akt activity from serum-
NIH 3T3 cell extracts. The complexes were washed tostarved Cdc42V12-transfected cells compared with
remove nonassociated proteins and subjected to immu-control samples (Figures 5D and 5E). These results
noblotting with anti-pp70S6k antibodies. pp70S6k wasstrongly suggest that Cdc42V12 does not activate
found to associatemost avidly with Cdc42, and complexpp70S6k throughthe activation of PI3K.Furthermore, they
formation was enhanced in the presence of GTPgS com-indicate that the basal activity of PI3K (and hence of
pared with GDP (Figure 6B). GST±Rac1 also associatedPI3K-dependent pp70S6k activating kinases) in serum-
with pp70S6k in a GTP-dependent fashion, albeit to astarved cells is necessary and sufficient to effect pp70S6k
activation in the presence of Cdc42V12 or Rac1V12. lesser degree than GST±Cdc42. No binding to RhoA was
observed. Thus, the ability of the different Rho family
members to bind to pp70S6k correlated with their abilityCdc42 and Rac1 Form a Complex
to activate pp70S6k in vivo. A low level of pp70S6k bindingwith pp70S6k In Vitro
to GST±Cdc42 was observed in the presence of GDP.Recent studies have identified several kinases that are
regulated by Cdc42 and Rac1. Among these are p65PAK This is likely to be an in vitro artifact, since pp70S6k
Cell
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were transfected with wild-type GST±Cdc42, alone or
in conjunction with pp70S6k (not epitope-tagged). Cell
extracts were supplemented with GTPgS. GST±Cdc42
was then immobilized on glutathione agarose beads and
immunoblotted for the presence of associated pp70S6k.
A low level of pp70S6k binding was observed in cells
expressing GST±Cdc42, in a GTPgS-dependent manner
(see Figure 6C). Binding was increased when cells were
cotransfected with pp70S6k, again only in the presence
of GTPgS. Confirming the results in Figure 6B, interac-
tion of Cdc42 was restricted to the hypophosphorylated
inactive forms of pp70S6k. Anti-GST blots confirmed that
expression of GST±Cdc42 was comparable in all sam-
ples (see Figure 6C). It is striking that despite vast dilu-
tion of cellular contents during lysis, pp70S6k and Cdc42
were able to reassociate when GTPgS was added. Using
this experimental approach, a low level of background
binding of pp70S6k was observed inCOS cells transfected
with the control GST-expressing vector. However, this
nonspecific association was GTPgS independent.
Cdc42 and pp70S6k Form a GTP-Dependent
Complex In Vivo That Is Resistant
to Wortmannin and Rapamycin
We tested the ability of pp70S6k and Cdc42 to form a
complex in vivo. As a control, we expressed a distinct
tagged version of Cdc42 and performed the reciprocal
immunoprecipitation/immunoblot as shown in Figure
6C. COS cells were transfected with either HA-Cdc-
Figure 5. Wortmannin and Rapamycin Block Activation of pp70S6k 42V12 or HA-Cdc42N17. Endogenous pp70S6k was
by Rac1V12/Cdc42V12, Even Though These G Proteins Do Not immunoprecipitated and probed for the presence of as-
Function via Activation of PI3K sociated Cdc42 by anti-HA blotting. Figure 7A demon-
(A) NIH 3T3 cells were cotransfected with HA-pp70S6k and Rac1V12 strates that pp70S6k forms a complex with HA-Cdc42V12.or pEBG. Cells were starved for 24 hr, then treated for 10 min with
The Cdc42V12 mutant exists primarily in a GTP-boundrapamycin (20 ng/ml) or wortmannin (100 nM) prior to addition of
PDGF. S6 kinase activity in anti-HA immunoprecipitates was mea- form in vivo, and it was therefore not necessary to sup-
sured. Results are representative of three experiments. plement the extract with GTPgS, as it was with wild-
(B) Whole cell lysates of transfectants in (A) were blotted with anti-
type Cdc42 in Figure 6C. In contrast, HA-Cdc42N17,HA antibody.
which exists predominantly in the GDP-bound form in(C) Quantitation of S6 phosphorylation in (A).
(D) HA-tagged Akt or pp70S6k was cotransfected with Cdc42V12 or vivo, failed to coprecipitate with pp70S6k (Figure 7A). This
pEBG. Cells were starved then stimulated with PDGF (50 ng/ml) for experiment demonstrates that Cdc42 associates with
10 min. The kinases were immunoprecipitated with anti-HA, then
pp70S6k in a GTP-dependent manner in vivo.subjected to in vitro kinase assays using S6 as substrate for pp70S6k
pp70S6k is phosphorylated in vivo both basally and in(right) or histone HIIIS for Akt (left).
(E) Anti-HA blots of anti-HA immunoprecipitates (left) or whole cell response to mitogens. Many of these residues have
lysates (right) confirmed comparable expression of epitope-tagged been mapped, and recently a number of wortmannin-
Akt and pp70S6k in the relevant samples. Detection with 125I protein
and rapamycin-sensitive sites have been identified.A (left) or ECL (right).
Such studies have shown that both drugs appear to
prevent the phosphorylation of a subset of the mitogen-
induced sites (Weng et al., 1995; Han et al., 1995; Pear-specifically interacted with the active GTP-bound form
son et al., 1995). We found that neither wortmannin norof Cdc42 in vivo (Figure 7A).
rapamycin had an effect on the association of pp70S6kAs mentioned above, pp70S6k appears as a quadruplet
with Cdc42V12 (Figure 7A). Thus, it appears that theof bands, only the highest of which is catalytically active.
phosphorylated residues targeted by wortmannin andStrikingly, the G proteins associated solely with the
rapamycin are not required for this interaction.hypophosphorylated catalytically inactive isoforms of
pp70S6k. That Cdc42-bound pp70S6k was devoid of activ-
ity was confirmed in kinase assays performed in parallel An Effector Domain Mutant of Cdc42 Is Deficient
Both in Binding and Activating pp70S6k(data not shown).
Binding of pp70S6k to Cdc42 was also examined using As mentioned above, mutations in the effector domain
of G proteins compromise their ability to interact withproteins expressed solely in mammalian cells. COS cells
p70 S6 Kinase Regulation by Rho G Proteins
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Figure 6. Cdc42 and Rac1, but Not RhoA,
Bind to Hypophosphorylated pp70S6k Iso-
forms in a GTP-Dependent Manner In Vitro
(A) GST fusions of Cdc42, Rac1, and RhoA
were purified from E. coli over a glutathione
affinity column. Proteins were eluted, frac-
tionated by SDS±PAGE, and Coomassie
stained.
(B) Extracts were prepared from NIH 3T3 cells
that were starved for 24 hr or stimulated with
20% serum for 30 min. GST fusion proteins
were loaded with the indicated guanine nu-
cleotide, added to cell extracts, then immobi-
lized on glutathione agarose beads. Nonas-
sociated proteins were washed away, and
complexes were fractionated by SDS±PAGE
and immunoblotted with anti-pp70S6k antise-
rum. Lanes labeled with asterisk are whole
cell lysates of growing cells and are shown
to clarify the relative position of the quad-
ruplet of pp70S6k bands.
(C) COS cells were transfected with control
vector or GST±Cdc42, either in the presence
or absence of pp70S6k (not epitope-tagged).
Lysates were prepared, then either supple-
mented with GTPgS or not. GST±Cdc42 was
immobilized on glutathione agarose beads,
and complexeswere washed, fractionated by
SDS±PAGE, then immunoblotted with anti-
pp70S6k (top) or anti-GST (bottom) antibodies.
targets and thereby block their biological activity. We by the expression of the nucleotide exchange factor
Dbl also stimulated pp70S6k. Using dominant negativegenerated an effector domain mutant of Cdc42 (Cdc-
42V12A35) that no longer associates with pp70S6k in vivo versions of Cdc42 and Rac1, we have shown that these
proteins mediate activation of pp70S6k by PDGF and EGF.(Figure 7A). This mutant concomitantly lost the ability
to activate pp70S6k in serum-starved cells (Figure 7B). In addition, we provide evidence as to how these G
proteins function by demonstrating that Cdc42 andThese results demonstrate a correlation between the
ability of Cdc42 to form a complex with pp70S6k and the Rac1 associate with pp70S6k in a GTP-dependent man-
ner. While other kinases such as p65PAK, JNK, and p38ability to activate it.
We have attempted to demonstrate growth factor± have been shown to be regulated by Cdc42/Rac, none
of these has a proven role in cell growth. Thus, ourinducible coprecipitation of wild-type Cdc42/Rac1 and
pp70S6k, but with no success. This is most likely due to studies identify a serine/threonine kinase with a demon-
strated role in cell proliferation that is regulated by Rhothe high basal GTPase activity of these G proteins and
to the transient nature of the interaction. family G proteins. Recently, it has been shown that Rac1
activity is required for transformation of rat fibroblastsGiven that Cdc42 and Rac1 selectively associate with
inactive pp70S6k isoforms and that overexpression of by oncogenic p21ras (Qiu et al., 1995), emphasizing the
importance of this pathway in growth control.these G proteins leads to pp70S6k activation in vivo, we
tested whether complex formation directly activates Our data are consistent with a model in which multiple
signals emanate from PI3K to effect pp70S6k activationpp70S6k. Incubation of GTP- or GTPgS-loaded Rac1 or
in response to growth factors (Figure 8). One of theseCdc42 with pp70S6k had no effect on its ability to phos-
leads to activation of Rac1 (Hawkins et al., 1995) andphorylate S6 (data not shown). This distinguishes
possibly to activation of Cdc42 (although this has notpp70S6k from p65PAK and suggests a distinct mechanism
been demonstrated formally). GTP-loading of Cdc42/of activation that is reminiscent of the regulation of Raf
Rac1 induces its association with basally phosphory-by p21ras.
lated catalytically inactive pp70S6k. This interaction is
insufficient to activate pp70S6k but may facilitate its rec-Discussion
ognition by upstream pp70S6k activating kinase(s), which
We have identified the pp70S6k signaling cascade as a are also regulated by PI3K, or alternatively phospholi-
novel pathway regulated by the Rho family of G proteins. pase Cg (PLCg) (Chung et al., 1994). This model is remi-
Expression of activated alleles of Cdc42 and Rac1 was niscent of the regulation of Raf by p21ras, in which inter-
sufficient to activate pp70S6k in transiently transected action is GTP dependent but does not directly activate
NIH 3T3 and BHK cells. Activation required both the the kinase (Zhang et al., 1993) and additional signals
effector domain and appropriate localization of the G are required for full activation (Reed et al.,1991; Williams
et al., 1992). Such a model would explain why wortman-proteins. Furthermore, activation of endogenous Cdc42
Cell
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Figure 8. Model of pp70S6k Activation
Treatment of cells with PDGF or EGF leads to the activation of
multiple signaling molecules, including PI3K and PLCg. PI3K medi-
ates the majority of pp70S6k activation in response to both growth
factors and stimulates GTP-loading of Cdc42/Rac1 (other agonists
may activate these G proteins by PI3K-independent pathways). This
allows them to complex with basally phosphorylated, catalytically
inactive pp70S6k. Interaction is insufficient to activate pp70S6k but mayFigure 7. Cdc42 and pp70S6k Form a GTP-Dependent Wortmannin-
facilitate its recognition by upstream pp70S6k activating kinase(s).and Rapamycin-Resistant Complex In Vivo
Candidate PI3K-regulated pp70S6k activating kinases are the non-
(A) COS cells were transfected with HA-tagged Cdc42V12, conventional PKCs (nPKCs) and Akt. PLCg signals through conven-
Cdc42N17, or the effector domain mutantCdc42V12A35. Cells were tional protein kinase C isoforms (cPKCs). Arrows from the nPKCs,
treated with wortmannin or rapamycin for 15 min where indicated. Akt, and cPKCs to pp70S6k do not indicate that these kinases act
Lysates were prepared, immunoprecipitated with anti-pp70S6k anti- on pp70S6k directly.
serum (cross-linked to protein A Sepharose), then immunoblotted
with anti-HA antibody. Detection was via ECL. The dark band visible
at the top of some of the immunoprecipitated lanes is the IgG light
chain. The identity of the pp70S6k activating kinases remains
(B) NIH 3T3 cells were cotransfected with HA-pp70S6k and the indi- unknown. Several candidates have been suggested
cated Cdc42 mutant alleles. pp70S6k activity was monitored by S6
based on their regulation by PI3K. One set of kinaseskinase assay (top) or anti-HA immunoblotting (bottom).
are thenonconventional protein kinase C (PKC) isoforms
d, e, h, and z, which are activated by the products of PI3K
(i.e., phosphatidylinositol [PI]3,4-bisphosphate [PI3,4P2]nin blocks Rac1V12/ Cdc42V12-mediated activation of
pp70S6k. Our results suggest that interaction of pp70S6k and PI3,4,5-trisphosphate [PIP3]) (Nakanishi et al., 1993;
Toker et al., 1994). Another candidate is Akt, a PKC-with Cdc42/Rac1 may be a rate-limiting event in this
process, since the V12 alleles stimulated pp70S6k activity related proto-oncogene, which is also regulated by PI3K
(Burgering and Coffer, 1995; Franke et al., 1995). In fact,under serum-starved conditions to levels induced by
growth factors. They also indicate that the basal activity coexpression with constitutively activated Akt has been
shown to stimulate pp70S6k activity in vivo (Burgeringof PI3K (and of the pp70S6k activating kinase) in these
cells is sufficient to activate pp70S6k. and Coffer, 1995). However, it remains to be determined
whether any of these kinases directly phosphorylatesWe have tried to determine whether this interaction
is direct using purified pp70S6k and GST±G proteins. and activates pp70S6k.
Activation of JNK by Cdc42 and Rac appears to beWhile we do observe GTP-dependent association of
Cdc42 and Rac1 that is specific for the catalytically independent of the ability of these G proteins to regulate
the cytoskeleton, since treatment of cells with cytocha-inactive forms of pp70S6k, the stoichiometry of binding
is low (data not shown). Therefore, it is possible that lasin D (which prevents actin polymerization) does not
affect the ability of Cdc42/Rac1 to activate JNK (Cosoadditional cellular factors may stabilize this interaction
in vivo. In contrast with PAK, pp70S6k does not contain et al., 1995). We have also observed that cytochalasin
D does not prevent activation of pp70S6k by Cdc42V12,a p21-binding domain (PBD), the consensus motif that
mediates interaction with Cdc42 and Rac. The p85 sub- Rac1V12, or growth factors (unpublished data). Further-
more, treatment of cells with rapamycin has no effect onunit of PI3K also lacks a PBD, and it therefore appears
that there may be two classes of Cdc42/Rac targets: membrane ruffling or stress fiber formation (unpublished
data). Together, these results support the notion thatthose that possess a PBD and those that do not.
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anti-myc from Babco. Anti-pp70S6k antibody was against app70S6k mediates signaling from Cdc42 and Rac that is
C-terminal peptide of the protein.unrelated to cytoskeletal restructuring.
The identification of Cdc42 and Rac as regulators of
GST Fishing Experiments and Coimmunoprecipitations
pp70S6k contributes to the expanding list of molecules GST fusion proteins were purified and eluted from glutathione aga-
on the pp70S6k signaling pathway that have pivotal roles rose beads as described previously (Chou et al., 1992). Proteins
were loaded with GTPgS or GDP as follows: 2 mg of G protein werein growth control and oncogenesis. As mentioned, Rac
incubated in 10 mM Tris (pH 7.5), 50 mM NaCl, 1 mM EDTA, 1 mMfunction is required for p21ras-induced transformation.
DTT, and 80 mM guanine nucleotide (total volume 30 ml) for 10 min
In addition, the GEF Dbl is an oncogene, originally identi- at 308C. MgCl2 was added to 5 mM, and half of this mixture was
fied for its effects in lymphoid cells (Eva and Aaronson, added to lysates of NIH 3T3 cells (250 ml) starved for 24 hr in DMEM
containing 0.5% FCS or stimulated for 30 min with 20% calf serum.1985). Similarly, akt is the transforming gene of a murine
GST fusions and associated proteins were immobilized by incuba-retrovirus that induces thymic lymphomas (Staal and
tion with glutathione agarose for 90 min at 48C, then washed three
Hartley, 1988). PI3K is a key mediator of mitogenesis in times in lysis buffer (Blenis et al., 1991). Glutathione agarose com-
response to oncogenes and growth factors. And, finally, plexes, as well as 25 ml of whole cell extract, were fractionated by
SDS±PAGE, transferred to nitrocellulose membranes, and probedFRAP possesses a crucial evolutionarily conserved role
with anti-pp70S6k antiserum. For Figure 6C, cells were lysed in 20in G1 progression. Together, this suggests the impor-
mM Tris (pH 7.2), 2 mM MgCl2, 50 mM b-glycerophosphate, 1 mM
tance of this pathway in the control of cellular prolifer- vanadate, 1 mM EGTA, 0.5% Nonidet P-40, 0.1% Brij-35, 1 mM DTT,
then either supplemented with 1 mM GTPgS or not. GST±Cdc42 oration.
GST was immobilized on glutathione agarose beads for 2 hr, washed
three times in the same buffer, and probed for the presence ofExperimental Procedures
associated pp70S6k. For Figure 7, COS cells were transfected with
the indicated G protein and lysed in the above buffer lacking EGTACell Culture and Transfections
and containing 150 mM NaCl. Lysates were incubated with anti-NIH 3T3 cells were maintained in Dulbecco's modified medium
pp70S6k or preimmune serum (cross-linked to protein A Sepharose(DMEM) containing 10% calf serum, BHK in DMEM containing 5%
with dimethylpimelimidate) for 45 min at 48C and washed three timescalf serum, and COS cells in DMEM containing 10% fetal calf serum
in the same buffer. Blots were probed with anti-HA antibody.(FCS). Cells were starved in DMEM containing 0.5% FCS for 24 hr.
All stimulations with PDGF (GIBCO BRL) were for 30 min and with
AcknowledgmentsEGF for 10 min, unless otherwise noted. NIH 3T3 cells were
transfected via the calcium phosphate method with 1 mg HA-pp70S6k
Correspondence should be addressed to John Blenis. We wish to(or myc-tagged MAPK), 2 mg carrier salmon sperm DNA, plus 9 mg
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